Identification of a PROM1 mutation in a Spanish family with inherited retinal dystrophies

Background: We report a Spanish family, comprising an affected mother and daughter, respectively diagnosed with retinitis pigmentosa and Stargardt-like macular dystrophy, in whom we identified a PROM1 mutation. Methods: A custom gene panel consisting of 119 inherited retinal dystrophies (IRD)-genes...

Descripción completa

Detalles Bibliográficos
Autores: Llavero-Valero, Pilar, Morillo-Sánchez, María José, Bravo-Gil, Nereida, Jiménez, Manuel Ramos, Ponte-Zuñiga, Beatriz, López-Domínguez, Mireia, Antiñolo Gil, Guillermo, Rodríguez de la Rúa Franch, Enrique
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/137404
Acceso en línea:https://hdl.handle.net/11441/137404
https://doi.org/10.2174/1874364102115010314
Access Level:acceso abierto
Palabra clave:PROM1
Prominin-1
Stargardt-like macular dystrophy
Retinitis pigmentosa
Macular dystrophy
Mutation
Descripción
Sumario:Background: We report a Spanish family, comprising an affected mother and daughter, respectively diagnosed with retinitis pigmentosa and Stargardt-like macular dystrophy, in whom we identified a PROM1 mutation. Methods: A custom gene panel consisting of 119 inherited retinal dystrophies (IRD)-genes was applied in the two affected individuals of this family and sequenced using the Illumina ́s NextSeq 500 platform. Results: The analysis of the resulting data allowed us to identify the pathogenic PROM1 mutation c.1117C>T (p.Arg373Cys) as the primary cause of the disease in both patients. No additional variants contributing to the extent of retinal dysfunction were detected. Conclusion: The variable expressivity of the detected PROM1 mutation is the most likely responsible for the intrafamilial phenotypic variability observed inthis family. Screening of this mutation should be considered in patients with compatible clinical manifestations, especially when accompanied by an autosomal dominant family history.